000 01238 a2200373 4500
005 20250518065228.0
008 ####s 0 0 eng d
022 _a1600-0641
024 7 _a10.1016/j.jhep.2019.09.013
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYau, Thomas
245 0 0 _aCorrigendum to "Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis" [J Hepatol 71 (2019) 543-552].
_h[electronic resource]
260 _bJournal of hepatology
_cDec 2019
300 _a1278 p.
_bdigital
500 _aPublication Type: Published Erratum
700 1 _aHsu, Chiun
700 1 _aKim, Tae-You
700 1 _aChoo, Su-Pin
700 1 _aKang, Yoon-Koo
700 1 _aHou, Ming-Mo
700 1 _aNumata, Kazushi
700 1 _aYeo, Winnie
700 1 _aChopra, Akhil
700 1 _aIkeda, Masafumi
700 1 _aKuromatsu, Ryoko
700 1 _aMoriguchi, Michihisa
700 1 _aChao, Yee
700 1 _aZhao, Huanyu
700 1 _aAnderson, Jeffrey
700 1 _aDela Cruz, Christine
700 1 _aKudo, Masatoshi
773 0 _tJournal of hepatology
_gvol. 71
_gno. 6
_gp. 1278
856 4 0 _uhttps://doi.org/10.1016/j.jhep.2019.09.013
_zAvailable from publisher's website
999 _c30255623
_d30255623